Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

ZMYM2 (fused in myeloproliferative disorders).


Other namesFIM (fused in myeloproliferative disorders).
ZNF198 (zinc finger protein 198).
LocusID (NCBI) 7750
Location 13q12.11
Location_base_pair Starts at 20532848 and ends at 20665984 bp from pter ( according to hg19-Feb_2009)  [Mapping]
Local_order proximal from FLT1 and FLT3
  FIM (13q12) - Courtesy Mariano Rocchi, Resources for Molecular Cytogenetics.


Description full length cDNA: 5,016 bp; a single open reading frame of 4,137 bp; alternative spliced cDNA variant
Transcription main transcripts: 5.0 and 7.5 kb


Description 1 379 amino acids; hydrophobic protein containing several motifs: a N-terminal cystein-rich region containing ten repeats with the consensus sequence C-X2-C-X18-24-F/Y-C-X3-C, which correspond to a novel zinc finger motifs, a highly hydrophobic proline-rich stretch, and a bipartite nuclear localization signal
Expression wide
Localisation cell nucleus and nucleolus; within the nucleolus, colocalizes with UBF (Upstream Binding Factor)
Function may be involved in the regulation of rRNA transcription
Homology FIM is related to DXS6673E, a gene which may be related with mental retardation

Implicated in

Entity t(8;13)(p12;q12)/ANLL-NHL --> 5' FIM - 3' FGFR1 ; stem-cell myeloproliferative disorder associated with the 8p12 chromosomal translocations; fused to the catalytic domain of FGFR1
Disease stem-cell myeloproliferative disorder characterized by myeloid hyperplasia, T -cell lymphoblastic leukemia/lymphoma and peripheral blood eosinophilia, and it generally progresses to acute myeloid leukemia; specific to the 8p12 chromosomal region
Prognosis very poor (median survival: 12 mths)
Cytogenetics usually, t(8;13)(p12;q12) occurs as a single anomaly; duplication of the der(13) was found during disease progression, suggesting that the crucial event might lie on this derivative chromosome; additional abnormalities:+8, +21
Hybrid/Mutated Gene 5' FIM - 3' FGFR1; localisation: der(13)
Abnormal Protein aberrant tyrosine kinase composed of the N-term two-thirds of FIM (retaining the 10 putative zinc finger motifs), and the FGFR1 intracellular region minus the major part of the juxtamembrane domain
Oncogenesis constitutive kinase activity of FGFR1 through constitutive activation of FGFR1 signal transduction pathways via constitutive dimerization capability mediated by the FIM N-term zinc finger sequences

Other Leukemias implicated (Data extracted from papers in the Atlas)

Leukemias 11q23ChildAMLID1615 11q23ID1030

External links

HGNC (Hugo)ZMYM2   12989
Entrez_Gene (NCBI)ZMYM2  7750  zinc finger, MYM-type 2
GeneCards (Weizmann)ZMYM2
Ensembl hg19 (Hinxton)ENSG00000121741 [Gene_View]  chr13:20532848-20665984 [Contig_View]  ZMYM2 [Vega]
Ensembl hg38 (Hinxton)ENSG00000121741 [Gene_View]  chr13:20532848-20665984 [Contig_View]  ZMYM2 [Vega]
ICGC DataPortalENSG00000121741
Genatlas (Paris)ZMYM2
SOURCE (Princeton)ZMYM2
Genomic and cartography
GoldenPath hg19 (UCSC)ZMYM2  -     chr13:20532848-20665984 +  13q11-q12   [Description]    (hg19-Feb_2009)
GoldenPath hg38 (UCSC)ZMYM2  -     13q11-q12   [Description]    (hg38-Dec_2013)
EnsemblZMYM2 - 13q11-q12 [CytoView hg19]  ZMYM2 - 13q11-q12 [CytoView hg38]
Mapping of homologs : NCBIZMYM2 [Mapview hg19]  ZMYM2 [Mapview hg38]
Gene and transcription
Genbank (Entrez)AF012126 AF035374 AF060181 AJ224901 AK226118
RefSeq transcript (Entrez)NM_001190964 NM_001190965 NM_003453 NM_197968
RefSeq genomic (Entrez)AC_000145 NC_000013 NC_018924 NG_023348 NT_024524 NW_001838069 NW_004929388
Consensus coding sequences : CCDS (NCBI)ZMYM2
Cluster EST : UnigeneHs.507433 [ NCBI ]
CGAP (NCI)Hs.507433
Alternative Splicing : Fast-db (Paris)GSHG0007961
Alternative Splicing GalleryENSG00000121741
Gene ExpressionZMYM2 [ NCBI-GEO ]     ZMYM2 [ SEEK ]   ZMYM2 [ MEM ]
SOURCE (Princeton)Expression in : [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
Protein : pattern, domain, 3D structure
UniProt/SwissProtQ9UBW7 (Uniprot)
NextProtQ9UBW7  [Medical]
With graphics : InterProQ9UBW7
Splice isoforms : SwissVarQ9UBW7 (Swissvar)
Domains : Interpro (EBI)DUF3504    TRASH_dom    Znf_MYM   
Related proteins : CluSTrQ9UBW7
Domain families : Pfam (Sanger)DUF3504 (PF12012)    zf-FCS (PF06467)   
Domain families : Pfam (NCBI)pfam12012    pfam06467   
Domain families : Smart (EMBL)TRASH (SM00746)  
DMDM Disease mutations7750
Blocks (Seattle)Q9UBW7
Human Protein AtlasENSG00000121741
Peptide AtlasQ9UBW7
IPIIPI00646199   IPI00941117   IPI00294603   IPI00640771   
Protein Interaction databases
IntAct (EBI)Q9UBW7
Ontologies - Pathways
Ontology : AmiGOcytosol  transcription, DNA-templated  regulation of transcription, DNA-templated  biological_process  zinc ion binding  PML body  ubiquitin conjugating enzyme binding  
Ontology : EGO-EBIcytosol  transcription, DNA-templated  regulation of transcription, DNA-templated  biological_process  zinc ion binding  PML body  ubiquitin conjugating enzyme binding  
REACTOMEQ9UBW7 [protein]
REACTOME PathwaysREACT_116125 Disease [pathway]
Protein Interaction DatabaseZMYM2
DoCM (Curated mutations)ZMYM2
Wikipedia pathwaysZMYM2
Gene fusion - rearrangements
Rearrangement : TICdbZMYM2 [13q12.11]  -  FGFR1 [15q14]
Polymorphisms : SNP, variants
NCBI Variation ViewerZMYM2 [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)ZMYM2
Exome Variant ServerZMYM2
Genetic variants : HAPMAPZMYM2
Genomic VariantsZMYM2  ZMYM2 [DGVbeta]
ICGC Data PortalENSG00000121741 
Somatic Mutations in Cancer : COSMICZMYM2 
CONAN: Copy Number AnalysisZMYM2 
LOVD (Leiden Open Variation Database)Whole genome datasets
LOVD (Leiden Open Variation Database)LOVD - Leiden Open Variation Database
LOVD (Leiden Open Variation Database)LOVD 3.0 shared installation
Impact of mutations[PolyPhen2] [SIFT Human Coding SNP] [Buck Institute : MutDB] [Mutation Assessor] 
DECIPHER (Syndromes)13:20532848-20665984
Mutations and Diseases : HGMDZMYM2
NextProtQ9UBW7 [Medical]
Disease Genetic AssociationZMYM2
Huge Navigator ZMYM2 [HugePedia]  ZMYM2 [HugeCancerGEM]
snp3D : Map Gene to Disease7750
DGIdb (Drug Gene Interaction db)ZMYM2
General knowledge
Homologs : HomoloGeneZMYM2
Homology/Alignments : Family Browser (UCSC)ZMYM2
Phylogenetic Trees/Animal Genes : TreeFamZMYM2
Chemical/Protein Interactions : CTD7750
Chemical/Pharm GKB GenePA37569
Clinical trialZMYM2
Cancer Resource (Charite)ENSG00000121741
Other databases
ProbeCancer Cytogenetics (Bari)
PubMed53 Pubmed reference(s) in Entrez


Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).
Popovici C, Adˆ©laˆØde J, Ollendorff V, Chaffanet M, Guasch G, Jacrot M, Leroux D, Birnbaum D, Pˆ©busque MJ
Proceedings of the National Academy of Sciences of the United States of America. 1998 ; 95 (10) : 5712-5717.
PMID 9576949
The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
Smedley D, Hamoudi R, Clark J, Warren W, Abdul-Rauf M, Somers G, Venter D, Fagan K, Cooper C, Shipley J
Human molecular genetics. 1998 ; 7 (4) : 637-642.
PMID 9499416
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Fletcher JA
Nature genetics. 1998 ; 18 (1) : 84-87.
PMID 9425908
Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.
Ollendorff V, Guasch G, Isnardon D, Galindo R, Birnbaum D, Pˆ©busque MJ
The Journal of biological chemistry. 1999 ; 274 (38) : 26922-26930.
PMID 10480903
ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain.
Xiao S, McCarthy JG, Aster JC, Fletcher JA
Blood. 2000 ; 96 (2) : 699-704.
PMID 10887137
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI


Written03-1998Jean-Loup Huret, Dominique Leroux
Department of Genetics, University Joseph Fourier, Grenoble, France
Updated01-2001Marie-Joséphe Pébusque


This paper should be referenced as such :
Pébusque, MJ
FIM (fused in myeloproliferative disorders).
Atlas Genet Cytogenet Oncol Haematol. 2001;5(1):27-28.
Free online version   Free pdf version   [Bibliographic record ]
History of this paper:
Pébusque, MJ. FIM (fused in myeloproliferative disorders).. Atlas Genet Cytogenet Oncol Haematol. 2001;5(1):27-28.

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sun Dec 21 03:10:09 CET 2014

Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us